Prognostic Role of Neutrophil to Lymphocyte Ratio at Diagnosis in Patients with Diffuse Large B-Cell Lymphoma.

Autor: Korkmaz, G, Ceran, F, Dağdaş, S, Güneş, AK, Sunu, C, Pepeler, MS, Pamukçuoğlu, M, Özet, G

Publikováno v: Nigerian Journal of Clinical Practice; Aug2024, Vol. 27 Issue 8, p1012-1019, 8p

Occurrence of granulocytic sarcoma after allogenic hematopoietic stem cell transplantation

Autor: Pamukcuoglu M, Pepeler MS, Ulkuden B, Gocun PU, Akyurek N, Akı SZ, Sucak GT

Publikováno v: Clinical Case Reports and Reviews. 4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3cf61639048ecd28ea8f017373f442b8
https://doi.org/10.15761/ccrr.1000382

What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Autor: Ulas T; University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology & Apheresis Unit, Ankara, Turkey. Electronic address: turgayulas@yahoo.com., Namdaroglu S; Dokuz Eylul University, Faculty of Medicine, Department of Hematology, Izmir, Turkey., Hindilerden IY; Istanbul University Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey., Erkurt MA; Inonu University, Faculty of Medicine, Department of Hematology, Malatya, Turkey., Erer K; University of Health Sciences, Kayseri Medical Faculty, Department of Hematology and Bone Marrow Transplantation Unit, Kayseri, Turkey., Yigenoglu TN; University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology & Apheresis Unit, Ankara, Turkey., Tiryaki TO; Istanbul University Istanbul Medical Faculty, Department of Internal Medicine, Division of Hematology, Istanbul, Turkey., Hidayet E; University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology & Apheresis Unit, Ankara, Turkey., Korkmaz S; University of Health Sciences, Kayseri Medical Faculty, Department of Hematology and Bone Marrow Transplantation Unit, Kayseri, Turkey., Ulu BU; University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology & Apheresis Unit, Ankara, Turkey., Yilmaz S; University of Health Sciences, Konya Medical Faculty, Department of Hematology and Bone Marrow Transplantation Unit, Konya, Turkey., Kaya E; Inonu University, Faculty of Medicine, Department of Hematology, Malatya, Turkey., Pepeler MS; Ankara Bilkent City Hospital, Department of Hematology and Bone Marrow Transplantation Unit, Ankara, Turkey., Basturk A; University of Health Sciences, Konya Medical Faculty, Department of Hematology and Bone Marrow Transplantation Unit, Konya, Turkey., Dal MS; University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology & Apheresis Unit, Ankara, Turkey., Altuntas F; University of Health Sciences, Ankara Oncology Training and Research Hospital, Department of Hematology & Apheresis Unit, Ankara, Turkey; Ankara Yildirim Beyazit University, School of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Turkey.

Publikováno v: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2024 Dec 17; Vol. 64 (1), pp. 104058. Date of Electronic Publication: 2024 Dec 17.

Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia

Autor: Pepeler MS; University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye, Dağdaş S; University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye, İşleyen E; University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye, Katayıfçı G; University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye, Kılıçarslan A; University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye, Özhamam E; University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye, Adakul MT; Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine (Intern), Ankara, Türkiye, Öztürk F; University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye, Ceran F; University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye, Özet G; University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Publikováno v: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Dec 02; Vol. 41 (4), pp. 288-290. Date of Electronic Publication: 2024 Nov 18.

Prognostic Impact of Bone Marrow Fibrosis and Effects of Tyrosine Kinase Inhibitors on Bone Marrow Fibrosis in Chronic Myeloid Leukemia.

Autor: Pepeler MS; Adult Hematology Deparment, Ankara Bilkent City Hospital, Ankara, Turkey. Electronic address: drsezgin44@gmail.com., Tıglıoglu M; Adult Hematology Deparment, Dıskapı Training and Research Hospital, Ankara, Turkey., Dagdas S; Adult Hematology Deparment, Ankara Bilkent City Hospital, Ankara, Turkey., Ozhamamcıoglu E; Pathology Department, Ankara Bilkent City Hospital, Ankara, Turkey., Han U; Pathology Department, Dıskapı Training and Research Hospital, Ankara, Turkey., Albayrak A; Pathology Department, Ankara Bilkent City Hospital, Ankara, Turkey., Aydın MS; Adult Hematology Deparment, Ankara Bilkent City Hospital, Ankara, Turkey., Korkmaz G; Adult Hematology Deparment, Ankara Bilkent City Hospital, Ankara, Turkey., Pamukcuoğlu M; Adult Hematology Deparment, Ankara Bilkent City Hospital, Ankara, Turkey., Ceran F; Adult Hematology Deparment, Ankara Bilkent City Hospital, Ankara, Turkey., Albayrak M; Adult Hematology Deparment, Dıskapı Training and Research Hospital, Ankara, Turkey., Ozet G; Adult Hematology Deparment, Ankara Bilkent City Hospital, Ankara, Turkey.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Apr; Vol. 24 (4), pp. e161-e167. Date of Electronic Publication: 2024 Jan 17.